From January to October, the total output of lithium batteries in China increased by 16% year-on-year. According to the Ministry of Industry and Information Technology, China's lithium-ion battery industry continued to grow from January to October 2024. According to the announcement of lithium battery industry norms, enterprise information and industry associations, the total output of lithium batteries in China from January to October was 890GWh, up 16% year-on-year. According to the data of the National Bureau of Statistics, the profit of China's lithium battery manufacturing industry increased by 39.4% from January to October. In the battery sector, the output of energy storage lithium batteries exceeded 200GWh from January to October. The loading capacity of power lithium batteries for new energy vehicles is about 405GWh. From January to October, the total export of lithium batteries in China reached 350.2 billion yuan, down 9.2% year-on-year, and the decline was 3.3 percentage points narrower than that in January-June.He ertai bought 199 million yuan and sold 155 million yuan in Shenzhen Stock Connect today. He ertai bought 199 million yuan and sold 155 million yuan today, with a turnover of 6.304 billion yuan and a turnover rate of 3.727%. After-hours data showed that the special seats of Shenzhen Stock Connect bought 199 million yuan and sold 155 million yuan.On the 13th, SSE 50 index futures fell by 2.58%, and the latest main contract positions changed as follows. According to the exchange data, as of December 13th, SSE 50 index futures closed at 2,412, up or down by -2.58%, with a turnover of 53,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,398 lots. The total number of contracts of SSE 50 index futures was 91,500 lots, an increase of 25,700 lots over the previous day. The first 20 seats in the contract held 88,200 lots, an increase of 2,257 lots over the previous day. The short positions in the top 20 seats of the contract were 113,700 lots, an increase of 1,701 lots over the previous day. (Sina Futures)
Coal stocks fluctuated lower Antai Group fell more than 6%, coal stocks fluctuated lower, Antai Group fell more than 6%, and mountain coal international, Dayou Energy, Shaanxi Black Cat, China Coal Energy and Lu 'an Huaneng followed suit.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) dropped by 100 yuan compared with the previous day, with an average price of 76,350 yuan/ton.The cultural media sector rose and strengthened, with more than 10 daily limit shares, including Tianyu Digital, Guangbo, Palm Reading Technology, vision china, Huizhou Intelligent, Guangdong Media, Tianxiaxiu and Lingnan.
Zhu Haoxiang, the Chinese director of the US SEC, resigned. The US Securities and Exchange Commission recently announced that Zhu Haoxiang, the director of the Trading and Marketing Department, will leave on December 10, 2024, and he will return to the Si Long School of Management at MIT to continue to serve as an associate professor of finance. As one of the important members of Gary Gensler, the current chairman of the SEC, Zhu Haoxiang was appointed by the SEC in December 2021. (Caixin. com)Organic fluorides in two underground waters in Tochigi Prefecture, Japan exceeded the standard. On the 13th, local time, it was learned that the government department of Tochigi Prefecture in Japan said on the same day that organic fluorides exceeding Japan's provisional safe range were detected in the underground waters of two wells located in Ghost Nuqiu, Zhengang City. (CCTV News)Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14